Lifeward Appoints Mark Grant as New Leader in Medical Tech
Lifeward Welcomes New CEO Mark Grant
Today, Lifeward Ltd. (NASDAQ: LFWD), a frontrunner in innovative medical technology aimed at transforming the lives of individuals with physical limitations, proudly announces the appointment of Mark Grant as its new President and Chief Executive Officer. His official start date is set for June 2, 2025. Larry Jasinski, the outgoing CEO, will continue to support the transition by serving in a Co-CEO capacity and providing advisory assistance until the end of June.
A New Era of Leadership
Mark Grant brings with him over three decades of rich experience in commercial leadership, channel development, and strategic solutions. His impressive background positions him perfectly to navigate Lifeward through its next growth phase. Joseph Turk, Chairman of the Lifeward Board of Directors, expressed enthusiasm about this new leadership, noting that Grant has effectively managed teams across various regions and has significantly contributed to vital functions ranging from sales to customer service.
Innovative Times Ahead
Upon his appointment, Mr. Grant shared his excitement about joining Lifeward at a pivotal moment in its journey. He highlighted the company's substantial achievements in recent times, including securing Medicare payment for their groundbreaking ReWalk exoskeleton. This significant milestone marks a new chapter of innovative treatments for individuals with spinal cord injuries, showcasing Lifeward’s commitment to enhancing lives through technology.
Harnessing Cutting-Edge Technologies
Grant believes that the ReWalk device symbolizes Lifeward’s dedication to creating impactful and life-changing solutions. The company’s extensive technical expertise and strong R&D capabilities lay the groundwork for continued innovation. As he steps into his role, Grant is focused on leveraging this expertise to foster sustainable growth and profitability, emphasizing the importance of building a robust foundation for the future.
Collaboration with Advocacy Groups
In his new capacity, Mr. Grant also expressed his eagerness to collaborate with partners in the patient advocacy community, all of whom are aligned with Lifeward's mission to improve the quality of life for those they serve. This collaboration will be vital in furthering Lifeward’s outreach and support mechanisms.
Mark Grant's Previous Achievements
Before joining Lifeward, Mr. Grant held notable positions at Medtronic, where he ascended to Vice President for the Americas. In this role, he successfully directed strategies that led to impressive revenue targets in competitive healthcare markets. His expertise includes opening up new commercial avenues, optimizing revenue cycle operations, and identifying fresh business opportunities. These experiences will be invaluable as he shapes the future strategies at Lifeward.
Leadership at IMRA Surgical
Prior to his tenure at Medtronic, Grant was the President of the Americas at IMRA Surgical, where he was integral in establishing operational strategies for ethical surgical procedures. His leadership fostered substantial growth within the company, ensuring a solid framework for innovative product lines.
Strategic Inducement Award
In light of his appointment, Lifeward’s Board of Directors has sanctioned an inducement award of 400,000 options to purchase ordinary shares of Lifeward. This award aligns with Nasdaq Listing Rule 5635(c)(4) and underscores the company’s commitment to Mr. Grant's success in his new role.
About Lifeward
Lifeward is dedicated to designing, developing, and commercializing transformative solutions that address the needs of individuals in rehabilitation and recovery. The company maintains a robust product portfolio that includes innovative solutions such as the ReWalk Exoskeleton and the AlterG Anti-Gravity system. Established in 2001, Lifeward operates globally, with significant footprints in various countries and a steadfast commitment to improving the well-being of those with physical disabilities.
Frequently Asked Questions
Who is the new CEO of Lifeward?
Mark Grant has been appointed as the new CEO of Lifeward, effective June 2, 2025.
What experience does Mark Grant bring to Lifeward?
Mark Grant has over 30 years of experience in commercial leadership and strategic solutions, having previously held significant roles at Medtronic and IMRA Surgical.
What is the significance of the ReWalk exoskeleton?
The ReWalk exoskeleton is a groundbreaking device that provides mobility solutions for individuals with spinal cord injuries, representing Lifeward's commitment to innovation in healthcare.
What does Lifeward aim to achieve under Mark Grant’s leadership?
Lifeward aims to continue its growth trajectory, enhance its product offerings, and work towards sustainable profitability while focusing on patient advocacy.
How has Lifeward recognized Mr. Grant's appointment?
The company has approved an inducement award of options to purchase shares as part of his employment agreement, emphasizing their expectation of success in his new role.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
